Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Paul Sekhri holds only 0.1 times base salary in stock. $84.78K of shares against $673.00K in salary for 2025.
Salary from the company's own proxy. The shares are what Paul Sekhri last reported holding, valued at $16.96, the price Class A Common Stock was last bought or sold at on the open market here, on 18 Nov 2024.
No percentages here. vTv Therapeutics Inc. reports its share count only per share class, which the XBRL frames API does not carry.
Nothing of that kind in this period.